ST三五(300051.SZ):控股股東龔少暉未減持股份 持股比例下降2.6%
格隆匯11月9日丨ST三五(300051.SZ)公佈,至2021年4月13日減持計劃披露時,公司控股股東、實際控制人龔少暉持有公司股份約1.1億股股份,佔公司總股本的30.07%,均為公司首次公開發行前已發行的實際可上市流通的股份;至2021年11月9日收盤時及本公吿披露前,龔少暉持有公司股份約1億股,佔公司總股本的27.48%,龔少暉所持股份數減少950萬股,持股比例下降2.6%。
前述持股變化系龔少暉與深圳市高新投集團有限公司發生相關糾紛、深圳市高新投集團有限公司向法院申請強制執行後拍賣過户所致,與本次減持計劃無關;龔少暉未發生本次減持計劃所述的減持情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.